Liu Nanyang, Ruan Juanjuan, Li Hao, Fu Jianhua
Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Department of Geriatrics, Zhumadian Hospital of Traditional Chinese Medicine, Zhumadian, Henan Province, China.
Front Neurosci. 2023 Oct 9;17:1112435. doi: 10.3389/fnins.2023.1112435. eCollection 2023.
Alzheimer's disease (AD) is a progressive neurodegenerative disease that disrupts cognitive function and severely affects the quality of life. Existing drugs only improve cognitive function and provide temporary relief of symptoms but do not stop or delay disease progression. Recently, natural medicines, especially Chinese herbal medicines, have gained attention in the treatment of AD due to their antioxidant, anti-inflammatory, and neuroprotective effects. However, conventional oral dosage forms lack brain specificity and have side effects that lead to poor patient compliance. Utilizing nanomedicine is a promising approach to improve brain specificity, bioavailability, and patient compliance. This review evaluates recent advances in the treatment of AD with nanoparticles containing various natural medicines. This review highlights that nanoparticles containing natural medicines are a promising strategy for the treatment of AD. It is believed that this technology can be translated into the clinic, thereby providing opportunities for AD patients to participate in social activities.
阿尔茨海默病(AD)是一种进行性神经退行性疾病,会扰乱认知功能并严重影响生活质量。现有药物仅能改善认知功能并暂时缓解症状,但无法阻止或延缓疾病进展。近来,天然药物,尤其是中草药,因其抗氧化、抗炎和神经保护作用而在AD治疗中受到关注。然而,传统口服剂型缺乏脑特异性,且具有副作用,导致患者依从性差。利用纳米药物是提高脑特异性、生物利用度和患者依从性的一种有前景的方法。本综述评估了含各种天然药物的纳米颗粒在AD治疗方面的最新进展。本综述强调,含天然药物的纳米颗粒是治疗AD的一种有前景的策略。人们相信,这项技术能够转化应用于临床,从而为AD患者参与社会活动提供机会。